(Date:12/4/2008)...swire-FirstCall/ -- Inverness Medical Innovations,...atient diagnostics, monitoring and health manageme...ce President, Finance, will attend the upcoming RB... held December 10-11, 2008 at the Westin Times Squ... is scheduled for Thursday, December 11, 2008 at ...
(Date:12/4/2008)...d ,idiosyncratic, study finds , , THURS...accine designed to protect against cervical cancer... doses. , That,s the assessment of Australian r...00 doses of the Gardasil vaccine were given to gir..., Gardasil protects against four types of human...
(Date:12/4/2008)...e-USNewswire/ -- Stem cells derived from bone marr...t a disease called epidermolysis bullosa (EB), a d...kin, according to a study pre-published online in ...ety of Hematology. , , Epidermolysis bullo...fragile skin and blistering on touch, akin to thir...
(Date:12/4/2008)...e/ -- Pittsburgh-based Foundation Radiology,Group... to be one of the 50,largest radiology groups in ...,Pittsburgh, FRG has been growing at a brisk pace...eaders and national experts. , In a little ...44th out of,50 nationally, proof that their busin...
Breaking Medicine News(10 mins):Health News:Inverness Medical Innovations to Present at RBC Capital Markets 2008 Healthcare Conference on December 11, 2008 2Health News:Cervical Cancer Vaccine Well Tolerated 2Health News:Bone Marrow-Derived Stem Cells May Offer Novel Therapeutic Option for Skin Disorder 2Health News:Bone Marrow-Derived Stem Cells May Offer Novel Therapeutic Option for Skin Disorder 3Health News:Bone Marrow-Derived Stem Cells May Offer Novel Therapeutic Option for Skin Disorder 4Health News:Foundation Radiology Group Named One of 50 Largest Radiology Groups in the Country 2(Date:12/4/2008)...o Advance to Clinical Trials , , SAN DIEGO,...nc., a biopharmaceutical company focused on the de...nists for the treatment of cancer, respiratory and...initiated a Phase I clinical trial of VTX-2337, a .... The multi-center clinical trial is being conduc...
(Date:12/3/2008)...irstCall/ -- Sangamo BioSciences, Inc.,(Nasdaq: ... update on milestones,achieved in 2008 and previe...and Analyst Briefing to be held in New York City t...a-Aldrich Corporation,s Research,Biotech Business...tial of the,two companies, collaboration to comme...
(Date:12/3/2008)...wswire-FirstCall/ -- Isis Pharmaceuticals,Inc. (...armaceuticals, Inc.,provided positive survival re...,OGX-011 in combination with docetaxel and prednis... prednisone alone ("the control arm") for first-li...state cancer. The current 10.6,month median over...
(Date:12/2/2008)...wswire-FirstCall/ -- Biopure Corporation,(Nasdaq:...cal Research Center,(NMRC) has submitted to the F...tigational new drug (IND) application to conduct a...ic Hemopure(R) [hemoglobin glutamer - 250 (bovine)...rauma patients. The study is,entitled "Operation ...
Breaking Medicine Technology:VentiRx Pharmaceuticals Commences Phase I Clinical Trial of VTX-2337, a Novel TLR8 Agonist for the Treatment of Oncology 2Sangamo BioSciences Provides Update on Company's 2008 Progress and 2009 Objectives 2Sangamo BioSciences Provides Update on Company's 2008 Progress and 2009 Objectives 3Sangamo BioSciences Provides Update on Company's 2008 Progress and 2009 Objectives 4Sangamo BioSciences Provides Update on Company's 2008 Progress and 2009 Objectives 5Sangamo BioSciences Provides Update on Company's 2008 Progress and 2009 Objectives 6Isis Announces That OGX-011 Has Shown Overall Survival Advantage in Prostate Cancer Compared to Standard Therapy in a Randomized Phase 2 Study 2Isis Announces That OGX-011 Has Shown Overall Survival Advantage in Prostate Cancer Compared to Standard Therapy in a Randomized Phase 2 Study 3Isis Announces That OGX-011 Has Shown Overall Survival Advantage in Prostate Cancer Compared to Standard Therapy in a Randomized Phase 2 Study 4U.S. Naval Medical Research Center Resubmits IND Application for Proposed 'Op RESUS' Clinical Trial in Trauma Patients in the Battlefield Setting 2U.S. Naval Medical Research Center Resubmits IND Application for Proposed 'Op RESUS' Clinical Trial in Trauma Patients in the Battlefield Setting 3Methods and Tools Used to Achieve Best Customer Satisfaction 21500 1Methods and Tools Used to Achieve Best Customer Satisfaction 21500 2Miami Institute Launches New Weight Loss Program 21496 1Miami Institute Launches New Weight Loss Program 21496 2Amick Shaw Join S C BlueCross Foundation Board 21492 1Study 3A Quick responses to influenza outbreaks reduces illness and death 21490 1Study 3A Quick responses to influenza outbreaks reduces illness and death 21490 2...IRE)--Jun 12, 2007 - Results from the,successful c...,OSCI) FACTIVE(R) (gemifloxacin mesylate) tablets ...neumonia of mild to moderate,severity (CAP) have b...ed Journal of Antimicrobial Chemotherapy, currentl...Phase III clinical,trial comparing a five-day and ...
...WIRE)--Jun 12, 2007 - Proprietary Pulsed,Electroma...,Technologies, Inc. (AMEX:II), improved neuron sur...lammation, researchers,reported today in a platfor...(BEMS,http://www.bioelectromagnetics.org) Annual ...iated with neuron death that occurs in,Parkinson,s...
Other Medicine Technology:July Issue of Journal of Antimicrobial Chemotherapy Highlights,Study of Factive Tablets for Five-Day Treatment of,Community-Acquired Pneumonia 2July Issue of Journal of Antimicrobial Chemotherapy Highlights,Study of Factive Tablets for Five-Day Treatment of,Community-Acquired Pneumonia 3July Issue of Journal of Antimicrobial Chemotherapy Highlights,Study of Factive Tablets for Five-Day Treatment of,Community-Acquired Pneumonia 4July Issue of Journal of Antimicrobial Chemotherapy Highlights,Study of Factive Tablets for Five-Day Treatment of,Community-Acquired Pneumonia 5Ivivi's PEMF Technology Significantly Improves Neuron Survival in,Parkinson's Disease Model, Study Finds 2Ivivi's PEMF Technology Significantly Improves Neuron Survival in,Parkinson's Disease Model, Study Finds 3...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
Medicine Products: